FindTrial
Sign In

Recombinant human follicle stimulating hormone (r-hFSH)

DRUG5 trials

Sponsors

EMD Serono, Merck KGaA, Darmstadt, Germany

Conditions

Hypogonadotropic HypogonadismInfertile Women Undergoing Assisted Reproductive Technology (ART)InfertilityOvulation InductionPolycystic Ovarian Syndrome

Phase 2

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
CompletedNCT01110707
Merck KGaA, Darmstadt, GermanyInfertility, Ovulation Induction
Start: 2005-01-10End: 2006-11-15Updated: 2018-03-27

Phase 3

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
CompletedNCT01185704
Merck KGaA, Darmstadt, GermanyPolycystic Ovarian Syndrome
Start: 2008-11-30End: 2012-02-29Updated: 2014-02-13

Phase 4

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
CompletedNCT00298025
EMD SeronoInfertile Women Undergoing Assisted Reproductive Technology (ART)
Start: 2003-09-30End: 2004-05-31Updated: 2014-03-26
Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])
TerminatedNCT00328926
EMD SeronoHypogonadotropic Hypogonadism
Start: 2006-03-31End: 2012-05-31Updated: 2013-08-07

Unknown Phase

GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)
CompletedNCT01100333
Merck KGaA, Darmstadt, GermanyInfertility
Start: 2008-04-30End: 2011-07-31Updated: 2014-07-31